Mirabegron elicits rat corpus cavernosum relaxation and increases in vivo erectile response

Autor(es)

de Oliveira, Mariana G. ^[1] ; Rojas-Moscoso, Julio Alejandro ^[1] ; Bertollotto, Gabriela M. ^[1] ; Candido, Tuany Z. ^[1] ; Kiguti, Luiz Ricardo de A. ^[1] ; Pupo, Andre S. ^[2] ; Antunes, Edson ^[1] ; De Nucci, Gilberto ^[1] ; Monica, Fabiola Z. ^[1]

Afiliação do(s) autor(es)

^[1] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, UNICAMP, BR-13083881 Campinas, SP - Brazil

^[2] Sao Paulo State Univ UNESP, Inst Biosci, Dept Pharmacol, Sao Paulo, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: European Journal of Pharmacology; v. 858, SEP 5 2019.
• Citações Web of Science: 1

Resumo

Mirabegron is the first beta 3-adrenoceptor agonist approved on the market and may offer beneficial pharmacological action in patients with overactive bladder and erectile dysfunction. Here, we further investigate the mechanisms by which mirabegron induces rat corpus cavernosum (CC) relaxation. Adult male Wistar rats were used. The CC were isolated for in vitro functional assays and beta-adrenoceptors subtypes mRNA expression evaluation. Animals were treated orally with mirabegron (30 mg/kg, 3 h), tadalafil (10 mg/kg, 3 h) or both for intracavernous pressure (ICP). Intracellular levels of cAMP and cGMP were also determined. The beta 1-, beta 2- and beta 3-adrenoceptors subtypes were expressed in rat CC. Mirabegron produced concentration-dependent CC relaxations that were unaffected by the beta 1-, beta 2- or beta 3-adrenoceptor antagonists atenolol (1 mu M), ICI-118,551 (1 mu M) and L748,337 (10 mu M), respectively. Mirabegron-induced relaxations were not affected by the phosphodiesterase type 4 inhibitor, rolipram, or the adenylyl cyclase selective inhibitor, SQ 22,536. Potassium channel-or calcium influx-blockade are not involved in mirabegron-induced relaxations. In contrast, mirabegron produced rightward shifts in the contractile response induced by the alpha 1-adrenoceptor agonist, phenylephrine. Finally, cavernous nerve stimulation caused frequency-dependent ICP increases, which were significantly increased in rats treated with mirabegron in a similar degree of tadalafil-treated rat, without promoting a significant cAMP or cGMP accumulation. Together, our results demonstrate that mirabegron induced CC relaxation through alpha 1-adrenoceptor blockade. Care should be taken to translate the effect of mirabegron into the clinic, especially when using rat as an animal model of erectile dysfunction. (AU)

• Processo FAPESP: 18/09765-3 - Disfunção miccional e prostática em ratos de meia-idade e camundongos obesos: enfoque na NADPH oxidase (NOx)
• Beneficiário: Mariana Gonçalves de Oliveira Taranto
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 13/13907-4 - Avaliação dos efeitos dos agonistas opiáceos em corpo cavernoso isolado de coelho e rato: o sistema opiáceo teria importância no controle da ereção?
• Beneficiário: Gilberto de Nucci
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 17/15175-1 - Modulação da guanilato ciclase solúvel e dos níveis intracelulares de nucleotídeos cíclicos em órgãos do trato urinário inferior e próstata
• Beneficiário: Edson Antunes
• Modalidade de apoio: Auxílio à Pesquisa - Temático